BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 50 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,313,960 | -9.0% | 13,779,000 | -7.3% | 0.00% | 0.0% |
| Q2 2023 | $14,628,363 | -32.6% | 14,870,000 | -29.7% | 0.00% | -50.0% |
| Q1 2023 | $21,705,635 | -1.5% | 21,156,000 | +2.3% | 0.00% | -33.3% |
| Q4 2022 | $22,029,959 | +24.2% | 20,679,000 | +16.4% | 0.00% | +50.0% |
| Q3 2022 | $17,732,000 | -0.1% | 17,761,000 | -1.0% | 0.00% | 0.0% |
| Q2 2022 | $17,747,000 | -7.1% | 17,944,000 | -6.8% | 0.00% | -33.3% |
| Q1 2022 | $19,110,000 | -9.2% | 19,257,000 | -4.3% | 0.00% | 0.0% |
| Q4 2021 | $21,050,000 | -19.9% | 20,132,000 | -21.5% | 0.00% | -25.0% |
| Q3 2021 | $26,282,000 | -2.3% | 25,654,000 | -1.3% | 0.00% | 0.0% |
| Q2 2021 | $26,899,000 | +3.1% | 25,992,000 | +1.7% | 0.00% | 0.0% |
| Q1 2021 | $26,089,000 | -9.0% | 25,551,000 | -5.5% | 0.00% | 0.0% |
| Q4 2020 | $28,684,000 | +13.9% | 27,042,000 | +12.9% | 0.00% | -20.0% |
| Q3 2020 | $25,191,000 | +0.9% | 23,942,000 | +17.2% | 0.01% | -16.7% |
| Q2 2020 | $24,974,000 | +26.0% | 20,430,000 | +6.8% | 0.01% | +20.0% |
| Q1 2020 | $19,815,000 | +385.1% | 19,123,000 | +389.5% | 0.01% | +400.0% |
| Q4 2019 | $4,085,000 | -7.3% | 3,907,000 | -13.5% | 0.00% | 0.0% |
| Q3 2019 | $4,408,000 | -20.5% | 4,518,000 | -15.8% | 0.00% | 0.0% |
| Q2 2019 | $5,547,000 | +80.6% | 5,363,000 | +78.6% | 0.00% | 0.0% |
| Q1 2019 | $3,072,000 | -26.4% | 3,002,000 | -28.5% | 0.00% | 0.0% |
| Q4 2018 | $4,172,000 | -5.1% | 4,197,000 | +0.4% | 0.00% | 0.0% |
| Q3 2018 | $4,395,000 | -32.5% | 4,180,000 | -34.8% | 0.00% | -50.0% |
| Q2 2018 | $6,511,000 | +65.4% | 6,409,000 | +53.0% | 0.00% | +100.0% |
| Q1 2018 | $3,936,000 | -38.2% | 4,189,000 | -34.8% | 0.00% | -50.0% |
| Q4 2017 | $6,369,000 | – | 6,427,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SHENKMAN CAPITAL MANAGEMENT INC | 30,138,000 | $29,510,000 | 3.72% |
| PFM Health Sciences, LP | 45,910,000 | $46,002,000 | 1.72% |
| Cheyne Capital Management (UK) LLP | 2,320,000 | $2,330,000 | 1.47% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 41,077,000 | $41,277,000 | 0.66% |
| SSI INVESTMENT MANAGEMENT LLC | 9,071,000 | $9,068,000 | 0.50% |
| PALISADE CAPITAL MANAGEMENT, LP | 14,548,000 | $14,612,000 | 0.34% |
| RWC Asset Management LLP | 7,500,000 | $7,552,000 | 0.21% |
| KBC Group NV | 400,000 | $40,316,000 | 0.15% |
| PROSPECTOR PARTNERS LLC | 1,000,000 | $1,000,000 | 0.12% |
| MACKAY SHIELDS LLC | 11,822,000 | $11,816,000 | 0.10% |